Filing Flows › Health Care › Cooper Companies (COO)

Cooper Companies (COO) earnings and revenue breakdown

Latest: Q3 FY26 · 10-Q filed Sep 9, 2026 · Cooper Companies (COO) Q3 FY26 earnings results →

Q3 FY26 Revenue up 1% year over year to $1.1B · 41¢ of every $1 of revenue kept as net profit · operating margin 20.8%

Cooper Companies made $1.1B in Q3 FY26 (+0.6% Y/Y). Operating margin 20.8%, net earnings $433M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Sep 9, 2026.

Revenue$1.1B

Year over year+0.6%

Operating margin20.8%

Net earnings$433M

Operating cash flow$342M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $1.1B in Q3 FY26, up 1% year over year and down 1% from the previous quarter.

Gross margin was 66.8%, up 1.5 points from Q3 FY25. Operating profit was $0.22B, a 20.8% margin (up 4.3 points year over year). Of the extra revenue versus Q3 FY25, 785% reached operating profit, above the 17% margin then. Operating expenses fell 5% while revenue rose 1%. Net earnings were $0.43B, up 340% year over year. The tax line was a benefit of $0.23B on pre-tax earnings of $0.20B.

Operating cash flow was $0.34B (up 31% year over year), 79% of net earnings. Non-cash charges added back $0.09B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items used $0.20B. Capital expenditures of $0.07B left free cash flow of $0.27B.

Quarterly history

Quarter	Form	Filed	Revenue	Y/Y	Op. margin	Net earnings	Op. cash flow
Q3 FY26	10-Q	Sep 9, 2026	$1.1B	+0.6%	20.8%	$433M	$342M
Q2 FY26	10-Q	Jun 5, 2026	$1.1B	+8%	-2.9%	−$77.9M	$183M
Q1 FY26	10-Q	Mar 6, 2026	$1.0B	+6%	20.8%	$131M	$261M
Q4 FY25	10-K	Dec 5, 2025	$1.1B	+5%	13.2%	$84.6M	$248M
Q3 FY25	10-Q	Aug 28, 2025	$1.1B	+6%	16.6%	$98.3M	$261M
Q2 FY25	10-Q	May 30, 2025	$1.0B	+6%	18.4%	$87.7M	$96.2M
Q4 FY24	10-K	Dec 6, 2024	$1.0B	+10%	19.5%	$118M	$268M

Charts

Latest (Q3 FY26): Y/Y +1%, Q/Q -1%.

From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.

Latest (Q3 FY26): Net income $433M, Operating cash flow $342M.

+0.8% since FY20: more shares outstanding (issuance, stock pay); earlier years scaled for the 4-for-1 split before FY22.

Ophthalmic Goods; dot size is quarterly revenue; dashed lines are the industry's medians.